Citius Oncology Inc Stock (CTOR) Forecast
The Citius Oncology Inc (CTOR) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.2563, representing a -48.75% decrease from the current price of $0.5001. The highest analyst price target is $0.4606, and the lowest is $0.052.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CTOR Price Target
Average 2.56 (+411.97% Downside)
Is Citius Oncology Inc (CTOR) A Buy Now?
Oscillators
Buy: 3 · Sell: 2 · Neutral: 2Summary: Buy
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, CTOR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CTOR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.98 indicates that CTOR is oversold. This indicates that CTOR price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 19.07 indicates that CTOR is oversold. This indicates that CTOR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.84 indicates that CTOR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 38.29 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of -53.47 indicates that CTOR is still oversold but not to an extreme extent.
Long-term CTOR price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Citius Oncology Inc financial reports and earnings history, Citius Oncology Inc (CTOR) stock could reach $4.05 by 2030, $6.50 by 2040 and $11.34 by 2050. See the projected annual prices until 2050 of the Citius Oncology Inc stock below:
- Citius Oncology Inc (CTOR) is expected to reach an average price of $1.98 in 2035, with a high prediction of $4.09 and a low estimate of $0.0346. This indicates an +296.85% change from the last recorded price of $0.5001.
- Citius Oncology Inc (CTOR) stock is projected to chart a bullish course in 2040, with an average price target of $3.67, representing an +634.57% change from its current level. The forecast ranges from a conservative $2.07 to a sky-high $6.50.
- Our analysts predict Citius Oncology Inc (CTOR) to change +970.92% by 2045, soaring from $4.18 to an average price of $5.36, potentially reaching $8.92. While $4.18 is the low estimate, the potential upside is significant.
- Citius Oncology Inc (CTOR) stock is expected to climb by 2050, reaching an average of $7.13, a +1,326% change from its current level. However, a wide range of estimates exists, with high and low targets of $11.34 and $6.29, respectively, highlighting the market's uncertainty.
Citius Oncology Inc Stock (CTOR) Year by Year Forecast
Citius Oncology Inc Stock (CTOR) Price Forecast for 2026
The predicted value for Citius Oncology Inc (CTOR) in 2026 is set at an average of $0.6998. Estimates vary from a peak of $1.37 to a trough of $0.0462, indicating an +39.93% surge from the present price of $0.5001.
Citius Oncology Inc Stock (CTOR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Citius Oncology Inc (CTOR) is $0.6239, with a high forecast of $5.12 and a low forecast of $0.00176. This indicates an +24.76% increase from the last price of $0.5001.
Citius Oncology Inc Stock (CTOR) Price Forecast for 2028
In 2028, Citius Oncology Inc (CTOR) is projected to reach an average price of $0.3335, with a high projection of $1.34 and a low estimate of $0.0169. This indicates an -33.32% fall from the last price of $0.5001.
Citius Oncology Inc Stock (CTOR) Price Forecast for 2029
The 2029 price forecast for Citius Oncology Inc Stock (CTOR) is $1.13 on average, with a high prediction of $1.67 and a low estimate of $0.00818. This represents an +126.32% increase from the previous price of $0.5001.
Citius Oncology Inc Stock (CTOR) Price Forecast for 2030
Citius Oncology Inc Stock (CTOR) is expected to reach an average price of $0.801 in 2030, with a high forecast of $4.05 and a low forecast of $0.0197. This signifies an +60.16% surge from the last price of $0.5001.
